Laos vs Tajikistan: The number of people with susceptibility test result for rifampicin
Laos
100
in 2021
Tajikistan
100
in 2021
Laos rank
2nd
Tajikistan rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Laos
- Tajikistan
How they compare
Laos currently reports 100 against 100 in Tajikistan, a difference of 0.
Across all 5 years both countries report, Tajikistan has been ahead every year.
Laos ranks 2nd and Tajikistan ranks 2nd of 146 countries.
Tajikistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Laos | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 64.84 | 100 | 35.16 | Tajikistan |
| 2020s | 94.5 | 100 | 5.5 | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Laos or Tajikistan?
- Laos, at 100 against 100 in Tajikistan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Laos and Tajikistan?
- 0, with Laos ahead.
- How many years of comparable data are there for Laos and Tajikistan?
- 5 years are reported by both, from 2017 to 2021.
- How do Laos and Tajikistan rank globally for the number of people with susceptibility test result for rifampicin?
- Laos ranks 2nd and Tajikistan ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.